BILL ANALYSIS

S4104

BEARISH

A bill to direct the Director of the Bureau of Justice Statistics to establish a database with respect to corporate offenses, and for other purposes.

S4104 (A bill to direct the Director of the Bureau of Justice Statistics to establish a database with respect to corporate offenses, and for other purposes.) carries an AI-assessed market impact score of 4/10 with a bearish outlook for investors. This legislation directly affects JPMorgan Chase ($JPM), Bank of America ($BAC), Wells Fargo ($WFC) and Microsoft ($MSFT) and 6 other tickers. The primary sectors impacted are Finance, Technology, Energy, Healthcare, Consumer and Manufacturing. View the full bill text on Congress.gov.

4/10

Impact Score

bearish

Market Sentiment

10

Affected Stocks

6

Sectors Impacted

Key Takeaways for Investors

1

The Corporate Crime Database Act of 2026 (S.4104) mandates a federal database for corporate enforcement actions, increasing transparency and potential legal/reputational risks for all public companies.

2

The bill is in an early legislative stage, having been referred to the Senate Judiciary Committee, and does not include explicit funding allocations.

3

All publicly traded companies, particularly those with complex operations, face increased compliance costs and regulatory scrutiny if this bill becomes law.

How S4104 Affects the Market

The Corporate Crime Database Act of 2026, if enacted, would structurally increase compliance costs and legal risks for all publicly traded companies. While the bill is in its early stages, its potential to publicly disseminate corporate enforcement actions could lead to heightened regulatory scrutiny and reputational damage across all sectors. This would affect major companies like JPMorgan Chase & Co. ($JPM) at $295.45, Bank of America Corporation ($BAC) at $50.06, Wells Fargo & Company ($WFC) at $81.85, Microsoft Corporation ($MSFT) at $372.88, Apple Inc. ($AAPL) at $258.86, Alphabet Inc. ($GOOGL) at $299.99, Amazon.com, Inc. ($AMZN) at $212.79, Exxon Mobil Corporation ($XOM) at $163.37, Chevron Corporation ($CVX) at $198.86, and Pfizer Inc. ($PFE) at $27.83. The current market data shows varied performance among these tickers, with most experiencing positive 7-day changes, suggesting the market has not yet priced in the potential long-term impact of this early-stage legislation. However, the long-term implications point to an environment of increased regulatory burden and potential for negative public perception from enforcement actions.

Bill Details

MetricValue
Bill NumberS4104
Impact Score4/10Certainty: Introduced/Referred · Financial Magnitude: No explicit funding identified · Strategic Weight: AI qualitative assessment: 7/10 · Market Penetration: 10 companies — very broad impact across 6 sectors
Market Sentimentbearish
Event Date
Affected SectorsFinance, Technology, Energy, Healthcare, Consumer, Manufacturing
Affected StocksJPMorgan Chase ($JPM), Bank of America ($BAC), Wells Fargo ($WFC), Microsoft ($MSFT), Apple ($AAPL), Alphabet ($GOOGL), Amazon ($AMZN), Exxon Mobil ($XOM), Chevron ($CVX), Pfizer ($PFE)
SourceView on Congress.gov →

Summary

The Corporate Crime Database Act of 2026 (S.4104) introduces a federal database for corporate offenses, increasing compliance costs and legal risks for all publicly traded companies. This legislation, currently in the early stages of referral to committee, mandates public dissemination of corporate enforcement actions, potentially leading to heightened regulatory scrutiny and reputational damage across all sectors. Companies with complex operations and existing regulatory issues face the most significant negative impact.

Full AI Market Analysis

S.4104, titled the "Corporate Crime Database Act of 2026," was introduced in the Senate on March 16, 2026, by Senator Durbin and cosponsored by Senator Blumenthal. The bill has been read twice and referred to the Committee on the Judiciary. This legislation directs the Director of the Bureau of Justice Statistics to establish a database collecting, aggregating, and analyzing information regarding enforcement actions related to corporate offenses, which includes violations or alleged violations of Federal law by business entities or individuals within their occupational roles. The database would be publicly accessible on the Bureau's internet website. This bill does not authorize or appropriate any specific funding amount. Instead, it mandates the creation and maintenance of a database by the Bureau of Justice Statistics, implying that the operational costs would be absorbed within existing agency budgets or require future appropriations. The mechanism of impact is regulatory; by increasing transparency around corporate enforcement actions, it aims to increase accountability and deter corporate misconduct. This increased transparency will likely lead to higher compliance costs for companies as they navigate enhanced scrutiny and potential reputational risks. Structural losers under this legislation include all publicly traded companies, particularly those with complex operations or a history of regulatory issues. The public dissemination of enforcement actions, including administrative, civil, or criminal actions, declinations, settlements, deferred prosecution agreements, or non-prosecution agreements, increases legal and reputational risks. Companies like JPMorgan Chase & Co. ($JPM), Bank of America Corporation ($BAC), Wells Fargo & Company ($WFC), Microsoft Corporation ($MSFT), Apple Inc. ($AAPL), Alphabet Inc. ($GOOGL), Amazon.com, Inc. ($AMZN), Exxon Mobil Corporation ($XOM), Chevron Corporation ($CVX), and Pfizer Inc. ($PFE) would all be subject to this increased scrutiny. Recent market data shows mixed performance across these large-cap companies. Over the last 7 days, $JPM is up +4.12% at $295.45, $BAC is up +5.99% at $50.06, and $WFC is up +6.58% at $81.85. Technology giants like $MSFT are up +3.88% at $372.88, $AAPL is up +4.96% at $258.86, $GOOGL is up +9.69% at $299.99, and $AMZN is up +5.89% at $212.79. In contrast, energy companies $XOM and $CVX are down -4.72% at $163.37 and -5.62% at $198.86, respectively. Pfizer ($PFE) is up +0.22% at $27.83. The introduction of S.4104 has not yet demonstrably impacted these stock prices, given its early legislative stage. The bill is currently in committee, meaning it must pass through the Judiciary Committee, potentially be amended, pass a Senate vote, then go through a similar process in the House of Representatives, and finally be signed by the President to become law. A related bill, HR4724, the Corporate Crime Database Act of 2025, is also in committee in the House, indicating bipartisan interest in the concept. The legislative path for S.4104 is in its initial stages. It has been referred to the Committee on the Judiciary. For the bill to advance, it would need to be considered and approved by this committee, then potentially debated and voted on by the full Senate. If passed by the Senate, it would then move to the House of Representatives for consideration, where it would undergo a similar committee and floor vote process. Given the existence of a related House bill (HR4724), there is some legislative alignment, but the process is lengthy and subject to change.

Stocks Affected by S4104

Sectors Impacted by S4104

Related Finance Legislation

Understand the Terms

Track Bills Like S4104 Daily

Get AI-analyzed alerts when Congress moves markets.

Become a Member →